Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component

a technology of ginsenoside and bcl-2, which is applied in the direction of anti-noxious agents, drug compositions, biocides, etc., can solve the problems of generating sunburn cells, mechanisms or factors to control the expression of bcl-2 in hacat cells derived from human skin, and have not yet been disclosed. to achieve the effect of inhibiting the downregulation of bcl-2, promoting bcl-2 expression, and reducing bcl-2

Inactive Publication Date: 2007-07-05
AMOREPACIFIC CORP
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention is about a new compound called ginsenoside F1, which is found in purified ginseng saponin. The inventors found that ginsenoside F1 protects human cells from UVB-induced apoptosis by maintaining constant levels of Bcl-2. This means that ginsenoside F1 controls the expression of Bcl-2 and prevents cells from dying. The invention provides an agent that can control Bcl-2 expression, as well as a promoter or inhibitor of apoptosis that contains ginsenoside F1 as an active component.

Problems solved by technology

When the skin is exposed to ultraviolet radiation, DNA, proteins, lipids, etc., in cells are damaged and thereby generate sunburn-cells.
However, over-expression of Bcl-2 prevents apoptosis of a cell with serious DNA damage and thereby causes a cancer.
However, mechanisms or factors to control the expression of Bcl-2 in HaCaT cells derived from human skin have not yet been disclosed.
In addition, a material for controlling the expression of Bcl-2 that is not toxic and is easily applied to the human body have not yet been disclosed.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component
  • Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component
  • Agent for controlling bcl-2 expression comprising ginsenoside f1 as an active component

Examples

Experimental program
Comparison scheme
Effect test

reference example 1

Preparation of Purified Ginseng Saponin

[0023] 2 kg of Red ginseng (KT&G Corporation, 6 year old red ginseng) was added into 4 l of methanol containing water, and refluxed 3 times then deposited for 6 days at 15° C. Residues and remainders were separated by filtration and centrifugation, then the remainders were concentrated under reduced pressure to obtain extract. The extract was suspended into the water and re-extracted with 1 l of ether 5 times to remove pigments, then water layer thereof was extracted with 500 ml of 1-butanol 3 times. The above-obtained 1-butanol layer was treated with 5% of KOH and washed with distilled water then concentrated under reduced pressure to obtain 1-butanol extract. The extract (1-butanol extract) was dissolved in a small amount of methanol, and a large amount of ethylacetate was added thereto to obtain precipitation. The precipitation was dried to obtain 70 g of purified ginseng saponin extract.

reference example 2

Preparation of Gensenoside F1

[0024] 10 g of purified ginseng saponin obtained from the Reference Example 1 was dissolved in 1000 ml of citrate buffer solution (pH 4.0), 15 g of naringinase obtained from penicillium sp. was added thereto and reacted for 48 hours while stirring at 40° C. After the reaction, reaction mixture was heated for 10 minutes to inactivate the enzyme, then the reaction mixture was extracted 3 times with same amount of ethylacetae and concentrated. The product obtained underwent column chromatography (chloroform:methanol=9:1) and finally separated 1.5 g of ginsenoside F1.

example 1

Inhibition of Apoptosis of HaCaT Cells Induced by Ultraviolet Radiation, when Treated with Ginsenoside F1

Cell Line and Cell Culture

[0025] Human keratinocyte, HaCaT (obtained from Dr. Fusenig in German Cancer Research Center (DKFZ)) was cultured in Dulbecco's modified Eagle's Medium (DMEM; Gibco 1210-0038) containing 10% of fetal bovin serum at 37° C. and 5% of CO2.

Inhibition of Apoptosis of Cells Induced by Ultraviolet Radiation, when Treated with Ginsenoside F1

[0026] Cells cultured in step 1 were treated with trypsin to obtain single cell suspension, and seeded into 6-well flask with 2×105 / well, then cultured for 24 hours. After that, the cells were cultured again in a new DMEM not containing fetal bovin serum for 24 hours, then treated with 1, 5, 10 μM of ginsenoside F1. Ginsenoside F1 was dissolved in 100% ethanol and added to be 1 / 1000 of the medium concentration. After 24 hours of treatment with ginsenoside F1, the cell cultures were washed with phosphate buffered saline ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
wavelengthaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component. [Formula 1]

Description

FIELD OF THE INVENTION [0001] The present invention relates to an agent for controlling Bcl-2 expression comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) represented by the following formula 1 as an active component. BACKGROUND OF THE INVENTION [0002] Ultraviolet radiation is a part of solar rays with 200-400 nm of wavelength and is a part of the electromagnetic spectrum; especially UVB (Ultraviolet-B) with 280-320 nm of wavelength is the major part of the ultraviolet radiation to cause skin aging leading to skin-burn and skin cancer. When the skin is exposed to ultraviolet radiation, DNA, proteins, lipids, etc., in cells are damaged and thereby generate sunburn-cells. These sunburn-cells undergo apoptosis, accompanied by DNA fragmentation, activation of caspase, and the like. High-dose radiation on the cell causes serious DNA damages that are not recovered from; and the apoptosis prevents the cell from developing to a tumor by inducing the cell to die. Th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/365A61K31/704A61K31/70
CPCA61K31/70A61P17/00A61P17/16A61P35/04A61P39/00A61P43/00A61K31/704
Inventor CHO, SI-YOUNGLEE, EUN-HEEKIM, SU-JUNGSHIN, EUI-SEOKCHANG, HUI-KYOUNGKIM, DUCK-HEEYEOM, MYEONG-HOONWOE, KWANG-SIKLEE, TAE-RYONGSIM, YOUNG-CHUL
Owner AMOREPACIFIC CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com